Cargando…
Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy
Renal‐cell carcinoma (RCC) is responsible for the majority of tumors arising from the kidney parenchyma. Although a progressive improvement in median overall survival has been observed after the introduction of anti‐PD‐1 therapy, many patients do not benefit from this treatment. Therefore, we have i...
Autores principales: | De Biasi, Sara, Guida, Annalisa, Lo Tartaro, Domenico, Fanelli, Martina, Depenni, Roberta, Dominici, Massimo, Finak, Greg, Porta, Camillo, Paolini, Annamaria, Borella, Rebecca, Bertoldi, Carlo, Cossarizza, Andrea, Sabbatini, Roberto, Gibellini, Lara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542732/ https://www.ncbi.nlm.nih.gov/pubmed/35507402 http://dx.doi.org/10.1002/cyto.a.24562 |
Ejemplares similares
-
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
por: Gibellini, Lara, et al.
Publicado: (2020) -
Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
por: Paolini, Annamaria, et al.
Publicado: (2021) -
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
por: De Biasi, Sara, et al.
Publicado: (2021) -
Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
por: Swatler, Julian, et al.
Publicado: (2022) -
Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
por: Paolini, Annamaria, et al.
Publicado: (2022)